NIH-funded research NIH-funded research

Understanding T Cells in Brain Disorders

Official title: The 2nd International "T Cells in the Brain (TCB2025): Decoding T Cell Targets in Neurodegeneration"

Funded at Columbia University Health Sciences · NIH-11000638 · Data updated 2026-11-12

This study is looking at how T cells, a type of immune cell, might affect brain diseases like Alzheimer's and ALS, and it brings together different experts to share ideas and find new ways to help treat these conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 15, 2024
Project endJune 30, 2025
Funding year2024
Award (this year)$28,315
NIH project number1R13AG090018-01
Project IDNIH-11000638 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with neurodegenerative diseases such as Alzheimer's disease or ALS.

Less likely to help

Patients with non-neurodegenerative conditions or those not affected by T cell-related immune responses may not benefit from this research.

What this research studies

This research focuses on the role of T cells in neurodegenerative diseases, particularly how they contribute to conditions like Alzheimer's and ALS. It aims to bring together experts from various fields to share knowledge and collaborate on identifying T cell targets for potential therapies. By fostering interdisciplinary discussions, the project seeks to enhance our understanding of T cell behavior in the brain and develop new treatment strategies. The initiative also emphasizes inclusivity by encouraging participation from diverse researchers.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic interventions targeting T cells, potentially improving outcomes for patients with neurodegenerative diseases.

How similar studies have gone: Previous research has shown promising results in understanding T cell roles in neuroinflammation, indicating that this approach has potential for significant breakthroughs.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Elyaman, Wassim — Columbia University Health Sciences
  • Study coordinator: Elyaman, Wassim

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.